Cargando…

Pituitary dysfunction in granulomatosis with polyangiitis

PURPOSE: Granulomatosis with polyangiitis (GPA) is a multisystem disease, characterized by necrotizing small-vessel vasculitis, which mainly affects the respiratory tract and the kidneys. Pituitary involvement in GPA is rare, present in about 1% of all cases of GPA. To date, only case reports or sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Esposito, Daniela, Trimpou, Penelope, Giugliano, Dario, Dehlin, Mats, Ragnarsson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606941/
https://www.ncbi.nlm.nih.gov/pubmed/28540625
http://dx.doi.org/10.1007/s11102-017-0811-0
_version_ 1783265214327685120
author Esposito, Daniela
Trimpou, Penelope
Giugliano, Dario
Dehlin, Mats
Ragnarsson, Oskar
author_facet Esposito, Daniela
Trimpou, Penelope
Giugliano, Dario
Dehlin, Mats
Ragnarsson, Oskar
author_sort Esposito, Daniela
collection PubMed
description PURPOSE: Granulomatosis with polyangiitis (GPA) is a multisystem disease, characterized by necrotizing small-vessel vasculitis, which mainly affects the respiratory tract and the kidneys. Pituitary involvement in GPA is rare, present in about 1% of all cases of GPA. To date, only case reports or small case series have been published. Herein we report clinical features, imaging findings, treatment and outcomes in three patients with GPA-related pituitary dysfunction (PD). METHODS: A retrospective analysis of three cases of GPA-related PD was conducted, followed by systematic review of the English medical literature using PubMed. RESULTS: The three cases include three women aged between 32 and 37 years. PD was the presenting feature in one and two developed PD in the course of the disease. All patients had a pituitary lesion on MRI. Conventional treatment with high doses of glucocorticoids and cyclophosphamide led to resolution or improvement of the MRI abnormalities, whereas it was not effective in restoring PD. A systematic review identified 51 additional patients, showing that GPA can lead to partial or global PD, either at onset or, during the course of the disease. Secondary hypogonadism is the predominant manifestation, followed by diabetes insipidus (DI). Sellar mass with central cystic lesion is the most frequent radiological finding. CONCLUSION: GPA should be carefully considered in patients with a sellar mass and unusual clinical presentation with DI and systemic disease. Although conventional induction-remission treatment improves systemic symptoms and radiological pituitary abnormalities, hormonal deficiencies persist in most of the patients. Therefore, follow-up should include both imaging and pituitary function assessment.
format Online
Article
Text
id pubmed-5606941
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-56069412017-10-04 Pituitary dysfunction in granulomatosis with polyangiitis Esposito, Daniela Trimpou, Penelope Giugliano, Dario Dehlin, Mats Ragnarsson, Oskar Pituitary Article PURPOSE: Granulomatosis with polyangiitis (GPA) is a multisystem disease, characterized by necrotizing small-vessel vasculitis, which mainly affects the respiratory tract and the kidneys. Pituitary involvement in GPA is rare, present in about 1% of all cases of GPA. To date, only case reports or small case series have been published. Herein we report clinical features, imaging findings, treatment and outcomes in three patients with GPA-related pituitary dysfunction (PD). METHODS: A retrospective analysis of three cases of GPA-related PD was conducted, followed by systematic review of the English medical literature using PubMed. RESULTS: The three cases include three women aged between 32 and 37 years. PD was the presenting feature in one and two developed PD in the course of the disease. All patients had a pituitary lesion on MRI. Conventional treatment with high doses of glucocorticoids and cyclophosphamide led to resolution or improvement of the MRI abnormalities, whereas it was not effective in restoring PD. A systematic review identified 51 additional patients, showing that GPA can lead to partial or global PD, either at onset or, during the course of the disease. Secondary hypogonadism is the predominant manifestation, followed by diabetes insipidus (DI). Sellar mass with central cystic lesion is the most frequent radiological finding. CONCLUSION: GPA should be carefully considered in patients with a sellar mass and unusual clinical presentation with DI and systemic disease. Although conventional induction-remission treatment improves systemic symptoms and radiological pituitary abnormalities, hormonal deficiencies persist in most of the patients. Therefore, follow-up should include both imaging and pituitary function assessment. Springer US 2017-05-24 2017 /pmc/articles/PMC5606941/ /pubmed/28540625 http://dx.doi.org/10.1007/s11102-017-0811-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Esposito, Daniela
Trimpou, Penelope
Giugliano, Dario
Dehlin, Mats
Ragnarsson, Oskar
Pituitary dysfunction in granulomatosis with polyangiitis
title Pituitary dysfunction in granulomatosis with polyangiitis
title_full Pituitary dysfunction in granulomatosis with polyangiitis
title_fullStr Pituitary dysfunction in granulomatosis with polyangiitis
title_full_unstemmed Pituitary dysfunction in granulomatosis with polyangiitis
title_short Pituitary dysfunction in granulomatosis with polyangiitis
title_sort pituitary dysfunction in granulomatosis with polyangiitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606941/
https://www.ncbi.nlm.nih.gov/pubmed/28540625
http://dx.doi.org/10.1007/s11102-017-0811-0
work_keys_str_mv AT espositodaniela pituitarydysfunctioningranulomatosiswithpolyangiitis
AT trimpoupenelope pituitarydysfunctioningranulomatosiswithpolyangiitis
AT giuglianodario pituitarydysfunctioningranulomatosiswithpolyangiitis
AT dehlinmats pituitarydysfunctioningranulomatosiswithpolyangiitis
AT ragnarssonoskar pituitarydysfunctioningranulomatosiswithpolyangiitis